Mytos
Robotic human cell manufacturing
What they do
Stem-cell derived regenerative medicines are currently manufactured manually, making them too expensive and unable to scale to meet patient demand.
Mytos provides a fully automated robotic platform that manufactures specific human cell types from stem cells over multi-week production runs.
Regenerative medicine companies and cell therapy manufacturers producing stem-cell derived cells for clinical treatments.
Founders
CEO and Co-Founder of Mytos. I'm a mixture between a scientist and an engineer, having solved challenges both using physics/chemistry, as well as through building hardware and software. I aspire to operate at the interface of science and engineering, where low level science translates into meaningful products.
Open roles 2
Company timeline
- YC batchSummer 2018
- StatusActive
- Team size26 people
- LocationLondon, England, United Kingdom
Similar startups
